- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT04814849
Parents' Occupation After Diabetes Onset (AMBA)
March 23, 2021 updated by: Heike Saßmann, Dr., Hannover Medical School
Long-term Occupational Consequences for Families of Children With Type 1 Diabetes: the Mothers Take the Burden
A cross-sectional multicenter study using a questionnaire assessing occupational and financial situation before and after the onset of type 1 diabetes was distributed to all families with a child diagnosed with type 1 diabetes before the age of 14 years in nine German pediatric diabetes centers.
Study Overview
Status
Completed
Conditions
Detailed Description
This cross-sectional multicenter study was conducted between January and June 2018 during a three months period per center.
The selected nine pediatric diabetes centers covered all regions of Germany.
The study participants were mothers, fathers, or other primary caregivers of children and adolescents diagnosed with type 1 diabetes before 14 years of age.
During a regularly scheduled medical visit, in Germany usually 4 per year, families were informed about the study procedure, its aims and anonymous data collection and analyses.
The answered questionnaires were either collected in a closed box in each diabetes center or could be sent anonymously via a prepaid envelope to the study administration center.
Study Type
Observational
Enrollment (Actual)
1144
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
Niedersachsen
-
Hannover, Niedersachsen, Germany, 30625
- Hannover Medical School
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
- Child
- Adult
- Older Adult
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Sampling Method
Non-Probability Sample
Study Population
Of 1470 eligible families in the nine centers, 1192 (81% response rate) agreed to participate and answered the questionnaire.
The majority of respondents to the questionnaire were mothers (n = 939; 82%).
Overall 48 questionnaires had to be excluded due to a high number of missing data.
Thus, the final sample consisted of n = 1144 answered questionnaires with information about both parents' occupational situation.
Description
Inclusion Criteria:
- mothers, fathers or other primary caregivers of children and adolescents diagnosed with type 1 diabetes before 14 years of age
- child's diabetes duration at least 12 months
- child's age under 19 years
Exclusion Criteria:
- caregivers unability to understand German language sufficiently
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Observational Models: Family-Based
- Time Perspectives: Cross-Sectional
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
occupational situation of parents
Time Frame: up to 12 weeks
|
questionnaire with 7 items to capture changes in occupational situation of parents after the onset of type 1 diabetes in their child
|
up to 12 weeks
|
number of participants reporting financial burden
Time Frame: up to 12 weeks
|
questionnaire to capture changes in occupational situation of parents after the onset of type 1 diabetes in their child
|
up to 12 weeks
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
number of participants reporting emotional and/or psychosocial burden
Time Frame: up to 12 weeks
|
questionnaire to capture psychosocial and emotional burden of parents in the year following the diagnosis of diabetes in a child
|
up to 12 weeks
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Collaborators
Investigators
- Study Director: Karin Lange, PhD, Hannover Medical School
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
December 1, 2017
Primary Completion (Actual)
June 30, 2018
Study Completion (Actual)
December 31, 2018
Study Registration Dates
First Submitted
March 18, 2021
First Submitted That Met QC Criteria
March 23, 2021
First Posted (Actual)
March 24, 2021
Study Record Updates
Last Update Posted (Actual)
March 24, 2021
Last Update Submitted That Met QC Criteria
March 23, 2021
Last Verified
March 1, 2021
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- 260320597
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
No
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Type 1 Diabetes
-
Poznan University of Medical SciencesUnknownDiabetes Mellitus Type 1 | Remission of Type 1 Diabetes | Chronic Complications of DiabetesPoland
-
Eledon PharmaceuticalsWithdrawnBrittle Type 1 Diabetes MellitusUnited States
-
National Institute of Allergy and Infectious Diseases...PPD; Rho Federal Systems Division, Inc.; Immune Tolerance Network (ITN)CompletedType 1 Diabetes Mellitus | T1DM | T1D | New-onset Type 1 Diabetes MellitusUnited States, Australia
-
Hoffmann-La RocheCompletedType 2 Diabetes, Type 1 DiabetesAustria, United Kingdom
-
Shanghai Changzheng HospitalRecruitingBrittle Type 1 Diabetes MellitusChina
-
Capillary Biomedical, Inc.TerminatedType 1 Diabetes | Type 1 Diabetes Mellitus | Diabetes Mellitus, Type I | Diabetes Mellitus, Insulin-Dependent, 1 | IDDMAustria
-
Capillary Biomedical, Inc.CompletedDiabetes Mellitus, Type 1 | Type 1 Diabetes | Type 1 Diabetes Mellitus | Diabetes Mellitus, Insulin-Dependent, 1Australia
-
AstraZenecaCompletedType 2 Diabetes Mellitus | Type 1 Diabetes MellitusUnited States
-
NYU Langone HealthNational Heart, Lung, and Blood Institute (NHLBI)Recruiting
-
Rabin Medical CenterDreaMed DiabetesTerminated